Seer, Inc.

Contributing Author

Recent Articles by Seer, Inc.

Dec-01	Nature Genetics Study Validates Seer's Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers SEER GlobeNewswire
Nov-07	Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025 SEER GlobeNewswire
Nov-06	Seer Reports Third Quarter 2025 Financial Results SEER GlobeNewswire
Oct-29	Seer to Participate in Upcoming November Investor Conferences SEER GlobeNewswire
Oct-16	Seer to Report Third Quarter 2025 Financial Results on November 6, 2025 SEER GlobeNewswire
Oct-10	Seer Highlights How Proteomics Complements Genomics to Advance Precision Medicine at American Society of Human Genetics (ASHG) 2025 SEER GlobeNewswire
Sep-02	Seer Appoints Isaac Ro to its Board of Directors SEER GlobeNewswire
Aug-26	Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference SEER GlobeNewswire
Aug-06	Seer Reports Second Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook SEER GlobeNewswire
Jul-31	Seer to Participate in the Canaccord Genuity 45th Annual Growth Conference SEER GlobeNewswire
Jul-22	Seer to Report Second Quarter 2025 Financial Results on August 6, 2025 SEER GlobeNewswire
Jun-01	Seer's Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults SEER GlobeNewswire
May-29	Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency SEER GlobeNewswire
May-13	Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook SEER GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 Finviz.com. All Rights Reserved.